Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovative Research of America is a specialized biotechnology company that pioneered the development of time-release pellet technology for preclinical research. The company's proprietary matrix-driven delivery system allows for the controlled, continuous release of hormones, chemicals, and other biologically active substances in animal models for periods ranging from several days to months. Their products are widely used in academic and pharmaceutical research to maintain steady-state concentrations of compounds, particularly in studies involving endocrinology, oncology, and pharmacology. By eliminating the need for frequent injections or oral dosing, their technology improves animal welfare and data consistency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovative Research of America.